3Suppliers
0Customers
2Debt Items
20Related Chains

Sionna Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
ABBV AbbVie Inc. 90% We have entered into license agreements with Sanofi and AbbVie, pursuant to which, among other things, we have secured exclusive licenses for certain intellectual property and know-how relating to CF…
ABBV AbbVie Inc. 90% Reciprocal relationship from ABBV graph: Reciprocal relationship from SION graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from SION graph: Reciprocal relationship from ABBV g…
SANOFI SANOFI 90% We have entered into license agreements with Sanofi and AbbVie, pursuant to which, among other things, we have secured exclusive licenses for certain intellectual property and know-how relating to CF…

Sionna Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Sionna Therapeutics, Inc..

Sionna Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SION-DEBT-12541 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
SION-DEBT Debt stack $8.4M 90% Market cache reports total debt of $8.4M.

Sionna Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sionna Therapeutics, Inc..

Sionna Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
SION-OWNER-RA-CAPITAL-MANAGEMENT-L-P RA CAPITAL MANAGEMENT, L.P. 90% 13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 122 tracked holders.

Sionna Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2